CoChat

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states. JNK-interacting protein-1 (JIP1) is a scaffolding protein that enhances JNK signaling by creating a proximity effect between JNK and upstream kinases. A minimal peptide region derived from JIP1 is able to inhibit JNK activity both in vitro and in cell. We report here a series of small molecules JIP1 mimics that function as substrate competitive inhibitors of JNK. One such compound, BI-78D3, dose-dependently inhibits the phosphorylation of JNK substrates both in vitro and in cell . In animal studies, BI-78D3 not only blocks JNK dependent Con A-induced liver damage but also restores insulin sensitivity in mouse models of type 2 diabetes. Our findings open the way for the development of protein kinase inhibitors targeting substrate specific docking sites, rather than the highly conserved ATP binding sites. In view of its favorable inhibition profile, selectivity, and ability to function in the cellular milieu and in vivo , BI-78D3 represents not only a JNK inhibitor, but also a promising stepping stone toward the development of an innovative class of therapeutics.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0805677105

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. R. S Pearlman CONCORD, Distributed by Tripos (St. Louis). (1998).

Cited by

See all 200

Metadata

Authors
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., Solinas, G., Karin, M., & Pellecchia, M.
Affiliations
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • Invitrogen Corporation, Invitrogen Discovery Services, 501 Charmany Drive, Madison, WI 53719; and
  • *Infectious and Inflammatory Disease Center, Cancer Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037;
  • University of California San Diego (US)
Corresponding author
Pellecchia, Maurizio
Venue
Proceedings of the National Academy of Sciences
Published
2008-10-28
Volume
105
Issue
43
Pages
16809-16813
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2007832743
Cited by
186
References
30
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 14 · 2019: 8 · 2018: 6 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 8 · 2013: 7 · 2012: 23
FWCI
8.92
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R24DK080263, R21DK073274)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
JNK, protein kinase inhibitors, c-Jun N-terminal kinase, type 2 diabetes, insulin sensitivity
MeSH terms
Animals, Binding, Competitive, Diabetes Mellitus, Experimental, Dioxanes, Insulin Resistance, Liver Diseases, Phosphorylation, Protein Binding, Thiazoles, Signal Transduction, Molecular Mimicry, Protein Kinase Inhibitors, JNK Mitogen-Activated Protein Kinases, Adaptor Proteins, Signal Transducing, Mice, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. https://app.cochat.ai/papers/10.1073/pnas.0805677105
The paper
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., Solinas, G., Karin, M., & Pellecchia, M. (2008). Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0805677105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.